SR9243 is primarily studied for its potential applications in cancer therapy. It functions as a modulator of metabolism, specifically targeting cancer cells by altering their metabolic pathways. This compound has shown promise in preclinical studies for its ability to inhibit the growth of tumors by disrupting the lipid metabolism that cancer cells rely on for energy. Researchers are exploring its use in combination with other therapies to enhance treatment efficacy, particularly in cancers that are resistant to conventional treatments. Additionally, SR9243 is being investigated for its role in reducing inflammation and its potential application in metabolic disorders, offering a broader scope of therapeutic benefits.